Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

DFP Healthcare Acquisitions (DFPH) Competitors

DFPH vs. TOI, SHLT, CCM, HIMS, TDOC, AUNA, SBC, LFMD, AIRS, and STRO

Should you be buying DFP Healthcare Acquisitions stock or one of its competitors? The main competitors of DFP Healthcare Acquisitions include Oncology Institute (TOI), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), AirSculpt Technologies (AIRS), and Sutro Biopharma (STRO).

DFP Healthcare Acquisitions vs.

DFP Healthcare Acquisitions (NASDAQ:DFPH) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

DFP Healthcare Acquisitions has higher earnings, but lower revenue than Oncology Institute.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DFP Healthcare AcquisitionsN/AN/A-$8.34MN/AN/A
Oncology Institute$378.93M0.13-$83.07M-$0.78-0.83

In the previous week, Oncology Institute had 1 more articles in the media than DFP Healthcare Acquisitions. MarketBeat recorded 1 mentions for Oncology Institute and 0 mentions for DFP Healthcare Acquisitions. Oncology Institute's average media sentiment score of 1.89 beat DFP Healthcare Acquisitions' score of 0.00 indicating that Oncology Institute is being referred to more favorably in the news media.

Company Overall Sentiment
DFP Healthcare Acquisitions Neutral
Oncology Institute Very Positive

DFP Healthcare Acquisitions has a net margin of 0.00% compared to Oncology Institute's net margin of -17.63%. DFP Healthcare Acquisitions' return on equity of -107.60% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
DFP Healthcare AcquisitionsN/A -107.60% -1.47%
Oncology Institute -17.63%-186.83%-34.58%

36.9% of Oncology Institute shares are owned by institutional investors. 9.5% of Oncology Institute shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Oncology Institute received 4 more outperform votes than DFP Healthcare Acquisitions when rated by MarketBeat users.

CompanyUnderperformOutperform
DFP Healthcare AcquisitionsN/AN/A
Oncology InstituteOutperform Votes
4
66.67%
Underperform Votes
2
33.33%

DFP Healthcare Acquisitions has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Summary

Oncology Institute beats DFP Healthcare Acquisitions on 7 of the 11 factors compared between the two stocks.

Remove Ads
Get DFP Healthcare Acquisitions News Delivered to You Automatically

Sign up to receive the latest news and ratings for DFPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DFPH vs. The Competition

MetricDFP Healthcare AcquisitionsOffices & Clinics Of Medical Doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$28.75M$1.17B$5.64B$8.08B
Dividend YieldN/AN/A4.89%4.04%
P/E RatioN/A15.4523.7319.00
Price / SalesN/A1.17381.75120.61
Price / CashN/A36.0138.0534.64
Price / Book-1.159.116.904.26
Net Income-$8.34M-$52.07M$3.18B$247.00M

DFP Healthcare Acquisitions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DFPH
DFP Healthcare Acquisitions
N/A$1.00
flat
N/AN/A$28.75MN/A0.00147,000
TOI
Oncology Institute
0.6996 of 5 stars
$0.61
-14.1%
N/A-61.8%$46.46M$378.93M-0.79660Positive News
Gap Up
SHLT
SHL Telemedicine
1.7439 of 5 stars
$2.35
-2.1%
$11.00
+368.1%
-61.9%$38.52M$55.94M0.00583News Coverage
Gap Down
CCM
Concord Medical Services
0.5597 of 5 stars
$4.27
-0.9%
N/A+4.7%$18.55M$471.70M0.00970Short Interest ↑
News Coverage
HIMS
Hims & Hers Health
2.4915 of 5 stars
$34.34
-4.5%
$37.23
+8.4%
+139.6%$7.99B$1.48B78.041,046Gap Up
High Trading Volume
TDOC
Teladoc Health
3.2759 of 5 stars
$8.93
-2.4%
$11.26
+26.1%
-42.3%$1.55B$2.57B-1.555,600
AUNA
Auna
3.7738 of 5 stars
$8.00
-2.4%
$13.53
+69.1%
N/A$591.34M$4.34B0.0014,958News Coverage
SBC
SBC Medical Group
N/A$3.29
+0.3%
N/AN/A$338.94M$223.34M0.00N/A
LFMD
LifeMD
1.9972 of 5 stars
$4.27
-8.6%
$11.14
+161.0%
-29.9%$202.27M$193.06M-6.67230Earnings Report
Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
High Trading Volume
AIRS
AirSculpt Technologies
1.3233 of 5 stars
$3.32
-2.1%
$5.00
+50.6%
-49.8%$192.17M$188.78M-23.71240News Coverage
Positive News
Gap Down
High Trading Volume
STRO
Sutro Biopharma
3.8898 of 5 stars
$1.35
-10.0%
$11.13
+724.1%
-71.3%$111.32M$160.96M-0.84240
Remove Ads

Related Companies and Tools


This page (NASDAQ:DFPH) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners